Company Filing History:
Years Active: 2009-2013
Title: A Profile of Inventor Jing Yang Wang
Introduction
Jing Yang Wang, based in Acton, MA, is an accomplished inventor with a significant contribution to the field of pharmaceutical science. With three patents to his name, he has made strides in developing innovative solutions for treating viral infections, particularly HIV.
Latest Patents
His latest patents focus on the development of enantiomerically pure phosphoindoles as HIV inhibitors. These 3-phosphoindole compounds are designed to exist primarily in the form of a single enantiomer, which is crucial for their efficacy against Flaviviridae virus infections. The patents not only describe the therapeutic compounds but also detail pharmaceutical compositions that incorporate these agents either alone or in conjunction with other antiviral medications. Furthermore, Wang's work outlines the processes for the compounds' preparation, along with methods for producing a medicament that includes these innovative compounds.
Career Highlights
Jing Yang Wang has made notable contributions during his tenure at various pharmaceutical companies, including Idenix Pharmaceuticals, Inc. and Novartis AG. His experience in these organizations has enabled him to align his research with cutting-edge pharmaceutical practices, ultimately leading to valuable advancements in the treatment of viral diseases.
Collaborations
Throughout his career, Wang has collaborated with distinguished colleagues, including Richard Storer and Adel M. Moussa. These collaborations have likely enriched his research environment and fostered innovative approaches in his work.
Conclusion
With his inventive spirit and dedication to scientific advancement, Jing Yang Wang remains a significant figure in the fight against viral infections. His contributions, through both his patents and collaborations, underscore the vital role that innovative thinking plays in developing therapeutic solutions in modern medicine.